Cefipime: Difference between revisions
Annhuang04 (talk | contribs) |
Annhuang04 (talk | contribs) |
||
| Line 7: | Line 7: | ||
* 1-2 g IV q12h | * 1-2 g IV q12h | ||
===febrile neutropenia=== | ====febrile neutropenia==== | ||
* 2g IV q8h | * 2g IV q8h | ||
===UTI, mild-mod=== | ====UTI, mild-mod==== | ||
* 0.5g - 1g q12h x 7-10days | * 0.5g - 1g q12h x 7-10days | ||
===UTI, severe=== | ====UTI, severe==== | ||
* 2g IV q12h x 10days | * 2g IV q12h x 10days | ||
Revision as of 00:36, 3 September 2015
General
- Type: cephalosporin (4th generation)
- Dosage Forms: IM/IV
- Common Trade Names: Maxipime
Adult Dosing
- 1-2 g IV q12h
febrile neutropenia
- 2g IV q8h
UTI, mild-mod
- 0.5g - 1g q12h x 7-10days
UTI, severe
- 2g IV q12h x 10days
Pediatric Dosing
Special Populations
- Pregnancy:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: